Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Capsoni F, Longhi M, Weinstein R.

Arthritis Res Ther. 2006;8(5):219. Review.

2.

Osteonecrosis of the jaw: more research needed.

Shane E, Goldring S, Christakos S, Drezner M, Eisman J, Silverman S, Pendrys D.

J Bone Miner Res. 2006 Oct;21(10):1503-5. No abstract available.

3.

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

Iwata K, Li J, Follet H, Phipps RJ, Burr DB.

Bone. 2006 Nov;39(5):1053-8. Epub 2006 Jun 27.

PMID:
16807159
5.

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Woo SB, Hellstein JW, Kalmar JR.

Ann Intern Med. 2006 May 16;144(10):753-61. Review. Erratum in: Ann Intern Med. 2006 Aug 1;145(3):235.

PMID:
16702591
6.

The long and the short of bone therapy.

Whyte MP.

N Engl J Med. 2006 Feb 23;354(8):860-3. No abstract available. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638.

PMID:
16495400
7.

Denosumab in postmenopausal women with low bone mineral density.

McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ; AMG 162 Bone Loss Study Group.

N Engl J Med. 2006 Feb 23;354(8):821-31.

8.

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Body JJ, Facon T, Coleman RE, Lipton A, Geurs F, Fan M, Holloway D, Peterson MC, Bekker PJ.

Clin Cancer Res. 2006 Feb 15;12(4):1221-8.

9.

Fully human therapeutic monoclonal antibodies.

Weiner LM.

J Immunother. 2006 Jan-Feb;29(1):1-9. Review.

PMID:
16365595
10.

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

Kostenuik PJ.

Curr Opin Pharmacol. 2005 Dec;5(6):618-25. Epub 2005 Sep 26. Review.

PMID:
16188502
11.

Human antibodies from transgenic animals.

Lonberg N.

Nat Biotechnol. 2005 Sep;23(9):1117-25. Review.

PMID:
16151405
12.

Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.

Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L.

Arthritis Rheum. 2005 Sep;52(9):2708-18.

13.

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.

Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM.

J Bone Miner Res. 2004 Jul;19(7):1059-66. Epub 2004 Mar 1.

15.

Regulatory effects of osteoprotegerin on cellular and humoral immune responses.

Stolina M, Guo J, Faggioni R, Brown H, Senaldi G.

Clin Immunol. 2003 Dec;109(3):347-54.

PMID:
14697750
16.

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators.

N Engl J Med. 2003 Sep 25;349(13):1207-15. Epub 2003 Sep 20.

17.

Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing.

Flick LM, Weaver JM, Ulrich-Vinther M, Abuzzahab F, Zhang X, Dougall WC, Anderson D, O'Keefe RJ, Schwarz EM.

J Orthop Res. 2003 Jul;21(4):676-84.

18.

Osteoclast differentiation and activation.

Boyle WJ, Simonet WS, Lacey DL.

Nature. 2003 May 15;423(6937):337-42. Review.

PMID:
12748652
19.

Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.

Valleala H, Laasonen L, Koivula MK, Mandelin J, Friman C, Risteli J, Konttinen YT.

J Rheumatol. 2003 Mar;30(3):468-73.

PMID:
12610803
20.

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.

Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ.

Cancer. 2003 Feb 1;97(3 Suppl):887-92.

Supplemental Content

Support Center